Fig. 6.
CD39+CD8+ T cells predict sunitinib therapeutic response. a, b TKI treatment responses (n = 85) in the group of CD8+ and the percentage of CD39+CD8+ cells
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.